Prescient Therapeutics Are Developing Game-Changing Cancer Treatments
Prescient Therapeutics (ASX: PTX) Managing Director and Chief Executive Officer Steven Yatomi-Clarke joins ASX Investor...
Prescient Therapeutics (ASX: PTX) Managing Director and Chief Executive Officer Steven Yatomi-Clarke joins ASX Investor...
Prescient Therapeutics (ASX: PTX) Managing Director and Chief Executive Officer Steven Yatomi-Clarke joins Kalkine Media...
Prescient Therapeutics (ASX: PTX) CEO Steven Yatomi-Clarke recently presented at the AusBiotech Investment Conference 2021....
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO Steven Yatomi-Clarke and Director of Scientific Affairs, Rebecca...
Researchers at the University of Pennsylvania (Penn) are developing a new way for cancer-fighting CAR-T...
Prescient Therapeutics (ASX: PTX) Managing Director and Chief Executive Officer Steven Yatomi-Clarke joins Small Caps...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO Steven Yatomi-Clarke is joined by special guest Professor...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO Steven Yatomi-Clarke is joined by special guests Professor...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO and MD Steven Yatomi-Clarke and Senior VP of...
Prescient Therapeutics Investor Briefing Prescient Therapeutics CEO Steven Yatomi-Clarke provides an in-depth look at the...
To stay up to date with Prescient Therapeutics news and events, please register your details.